Similar articles for PMID: 10770343

Year	Number of Results
1994	1
1995	2
1996	2
1997	4
1998	10
1999	8
2000	14
2001	5
2002	10
2003	5
2004	5
2005	4
2006	2
2007	6
2008	4
2009	2
2011	1
2012	3
2013	5
2014	8
2015	2
2016	3
2017	1
2018	2
2019	6
2020	1
2021	3
2022	5
2023	1
2024	0

1

Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.

Walmsley S, Northfelt DW, Melosky B, Conant M, Friedman-Kien AE, Wagner B. Walmsley S, et al. J Acquir Immune Defic Syndr. 1999 Nov 1;22(3):235-46. doi: 10.1097/00126334-199911010-00004. J Acquir Immune Defic Syndr. 1999. PMID: 10770343 Clinical Trial.

2

Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.

Bodsworth NJ, Bloch M, Bower M, Donnell D, Yocum R; International Panretin Gel KS Study Group. Bodsworth NJ, et al. Am J Clin Dermatol. 2001;2(2):77-87. doi: 10.2165/00128071-200102020-00004. Am J Clin Dermatol. 2001. PMID: 11705307 Clinical Trial.

3

Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.

Duvic M, Friedman-Kien AE, Looney DJ, Miles SA, Myskowski PL, Scadden DT, Von Roenn J, Galpin JE, Groopman J, Loewen G, Stevens V, Truglia JA, Yocum RC. Duvic M, et al. Arch Dermatol. 2000 Dec;136(12):1461-9. doi: 10.1001/archderm.136.12.1461. Arch Dermatol. 2000. PMID: 11115156 Clinical Trial.

4

Alitretinoin.

Cheer SM, Foster RH. Cheer SM, et al. Am J Clin Dermatol. 2000 Sep-Oct;1(5):307-14; discussion 315-6. doi: 10.2165/00128071-200001050-00005. Am J Clin Dermatol. 2000. PMID: 11702321 Review.

5

Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.

Miles SA, Dezube BJ, Lee JY, Krown SE, Fletcher MA, Saville MW, Kaplan L, Groopman J, Scadden DT, Cooley T, Von Roenn J, Friedman-Kien A; AIDS Malignancy Consortium. Miles SA, et al. AIDS. 2002 Feb 15;16(3):421-9. doi: 10.1097/00002030-200202150-00014. AIDS. 2002. PMID: 11834954 Clinical Trial.

6

Alitretinoin (Panretin) gel 0.1%.

Rhoads J. Rhoads J. J Assoc Nurses AIDS Care. 2001 Sep-Oct;12(5):86-91. doi: 10.1016/S1055-3290(06)60266-5. J Assoc Nurses AIDS Care. 2001. PMID: 11565242 Review.

7

Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.

Dedicoat M, Vaithilingum M, Newton R. Dedicoat M, et al. Cochrane Database Syst Rev. 2003;(3):CD003256. doi: 10.1002/14651858.CD003256. Cochrane Database Syst Rev. 2003. PMID: 12917957 Updated. Review.

8

[Kaposi's sarcoma treated with topical alitretinoin].

González de Arriba A, Pérez-Gala S, Goiriz-Valdés R, Ríos-Buceta L, García-Díez A. González de Arriba A, et al. Actas Dermosifiliogr. 2007 Jan-Feb;98(1):50-3. Actas Dermosifiliogr. 2007. PMID: 17374335 Free article. Spanish.

9

Recent advances in the treatment of AIDS-related Kaposi's sarcoma.

Cattelan AM, Trevenzoli M, Aversa SM. Cattelan AM, et al. Am J Clin Dermatol. 2002;3(7):451-62. doi: 10.2165/00128071-200203070-00002. Am J Clin Dermatol. 2002. PMID: 12180893 Review.

10

9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.

Aboulafia DM, Norris D, Henry D, Grossman RJ, Thommes J, Bundow D, Yocum RC, Stevens V. Aboulafia DM, et al. Arch Dermatol. 2003 Feb;139(2):178-86. doi: 10.1001/archderm.139.2.178. Arch Dermatol. 2003. PMID: 12588223 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year